We bought some Merck this week and left room to add more on a pullback closer to 40. Looking at a monthly chart, the stock has just broken through roughly 12 years’ worth of resistance. There’s an almost 4% dividend yield along with a new osteoporosis drug coming soon that could be a big deal.
Last night I talked about the stock for the Fast Money Web Extra:
Please note: My comments here are not individually tailored advice geared toward you or your own financial situation. Please consult your own adviser or the gypsy what gives you stock ideas down at the fairgrounds.